Evaluating the Efficacy of Primary Treatment for Graves’ Disease Complicated by Thyrotoxic Periodic Paralysis

Table 2

Clinical and biochemical profiles of the 16 patients on the presentation of GD/TPP.

	Number (%)/median (range)
Systolic blood pressure (mmHg)	131 (90–154)
Diastolic blood pressure (mmHg)	77 (69–99)
Heart rate (beats/min)	100 (66–138)
Body temperature (°C)	37.0 (36.7–37.2)
TSH (normal: 0.35–4.78 mIU/L)	0.03 (0.01–0.18)
Free T4 (normal: 12–23 pmol/L)	57.5 (24.1–140)
K^+ (normal: 3.6–5.0 mmol/L)	2.7 (1.2–3.4)
Precipitating/exacerbating factors
Heavy meals	4 (25.0%)
Alcohol intake	3 (18.8%)
Acute upper respiratory infection	2 (12.5%)
Strenuous exercise	1 (6.3%)
No factor identified	7 (43.8%)

TSH: thyroid stimulating hormone; K⁺: serum potassium.